NS Pharma, Inc. (NSP) is a biopharmaceutical leader in delivering life-changing care to people living with complex, rare diseases, backed by over 100 years of Nippon Shinyaku Co. development expertise. We commercialize innovative therapies for people living with rare diseases including debilitating genetic disorders, such as Duchenne muscular dystrophy (DMD) and Hunter Syndrome. By leveraging our passionate relationships with patients, caregivers, advocacy groups, and healthcare professionals we strive to address unmet needs, understand the integrated patient journey and seize opportunities for furthering impactful innovation. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-licensing them to the world.
Looking for a particular NS Pharma, Inc. employee's phone or email?
NS Pharma, Inc. Questions
The NS Pharma, Inc. annual revenue was $12.8 million in 2026.
Koji Kimura is the Vice President Of Business Development of NS Pharma, Inc..
126 people are employed at NS Pharma, Inc..
NS Pharma, Inc. is based in Paramus, New Jersey.
The NAICS codes for NS Pharma, Inc. are [32541, 325, 3254, 32].
The SIC codes for NS Pharma, Inc. are [283, 28].
Top NS Pharma, Inc. Employees
-
24
-
Donald Foy
Vice President, Commercial at NS Pharma, Inc.
St. Augustine, FL, US34 -
Dan Dunham
General Counsel at NS Pharma, Inc.
New York, NY, US22 -
13
-
Stephen Sudovar
Head of US Marketing at NS Pharma, Inc.
New York, NY, US35 -
Geet Mankad
Head of Regulatory Affairs at NS Pharma, Inc.
New York, NY, US32 -
11
-
Sanae Yasuda
Head of Clinical Pharmacology at NS Pharma, Inc.
New York, NY, US1
Related Companies
